MetaCap

Contineum Therapeutics Statistics

NASDAQ: CTNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.68-0.36 (-3.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Contineum Therapeutics by the numbers

Contineum Therapeutics has a market capitalization of $340.8 million based on 35.35M shares outstanding. With trailing EPS of $-1.77, Contineum Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.6% below its 50-day average and 34.6% below its 200-day average.

Average daily trading volume is 776.03K shares, or about $6.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CTNM valuation vs. peer median

CTNM compared with the median of 8 peer companies
MetricCTNMPeer medianDifference
Market cap$340.83M$343.21M-1%
Avg. volume776.03K919.30K-16%

Peer median across 8 companies: MPLT, INO, LRMR, PEPG, ASPE, AVIR, PBYI, PHAT.

Valuation

Price and trading

Previous close
9.04
Open
8.87
Day range
8.50 – 9.09
52-week range
6.73 – 17.79
52-week change
-20.69%
Beta
—
Volume
369.21K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
340.83M
Forward Pe
-4.13
Eps
-1.77
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
17.79
Week52 Low
6.73
Avg Volume
776.03K
Shares Outstanding
35.35M
Ma50
10.66
Ma200
13.27
Earnings Date
Nov 3, 2026
Pct From52w High
-51.19%
Pct From52w Low
29.07%

Related